Home
Dashboard
Bookmarks
Portfolios
ExplorerFunds
Equities
Library
Insights
Pinindices
MobileApp Store
Android

Biotechnology

Next 60 Small-Cap BiotechSelection of small market cap biotech firms, below $2 billion
Next 60 Small-Cap Biotech
  • 76.3%
  • 60
US NASDAQ 100 ETFsA selection of ETFs seeking to track NASDAQ indices and factors, with a range of filters and of option overlays
US NASDAQ 100 ETFs
  • 22.7%
  • 10
Healthcare Innovation ETFsDeeply transformative healthcare expectations or ever hopeful promises of basic research advance
Healthcare Innovation ETFs
  • 44.2%
  • 9
Global Health Care ETFsDedicated funds with distinct performance / volatility profiles and investment options
Global Health Care ETFs
  • 38.5%
  • 16
Biotechnology Breakthroughs ETFsDiversified selections or focused investment models in Biotech R&D
Biotechnology Breakthroughs ETFs
  • 61.9%
  • 10
30 Biotech LargeCap Firms The biotech firms, with market capitalization exceeding $10 billion, are strong contributors to the industry's performance - Momentum is indicative of the sector's resilience
30 Biotech LargeCap Firms
  • 66.6%
  • 30
Biotechnology - Top 100 by Market CapTargeted access to a large selection of biotechnology and pharmaceutical stocks (large-, mid- and small-cap)
Biotechnology - Top 100 by Market Cap
  • 99.7%
  • 100
Next 60 MidCap Biotech FirmsWith market capitalizations between $2bn and $10bn, the performance of the midcap biotech selection has gained momentum
Next 60 MidCap Biotech Firms
  • 113.4%
  • 61
China Biotech - Rising Stars ?Concentrating minds on breakthrough medication - Chinese biotech with a mission
China Biotech - Rising Stars ?
  • 6.9%
  • 11
  • 2